Cargando…

Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report

BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xi, Yuan, Mingming, Li, Zhuoguang, Ying, Yanqin, Hou, Ling, Luo, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411534/
https://www.ncbi.nlm.nih.gov/pubmed/34470639
http://dx.doi.org/10.1186/s12920-021-01057-z
_version_ 1783747313003397120
author Yang, Xi
Yuan, Mingming
Li, Zhuoguang
Ying, Yanqin
Hou, Ling
Luo, Xiaoping
author_facet Yang, Xi
Yuan, Mingming
Li, Zhuoguang
Ying, Yanqin
Hou, Ling
Luo, Xiaoping
author_sort Yang, Xi
collection PubMed
description BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the clinical data and genetic test results from a patient with IGHD admitted in March 2019 to the Department of Pediatrics Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. We described the results from a 1-year-9-months old female, whose chief complaint was “growth retardation for more than one year”. Her birth length was 49.0 cm, and her birth weight was 3.05 kg. Suboptimal intake (breastfeeding) jaundice lasted for approximately two months following birth. When evaluated at the age of 1-year-9-months old, the patient’s height was 61.0 cm (− 7.24 SD), and her weight was 6.4 kg (− 1.50 SD). The patient’s physical characteristics included yellowish hair, large and unclosed anterior fontanelles, raised forehead, and a low and flat nose. The major abnormalities observed from the auxiliary examinations included low GH (< 0.05 μg/l), low IGF-1 (16.99 μg/l), and elevated TSH (6.97 mIU/l). Genetic testing revealed two heterozygous variants: a splicing mutation (NG_011676.1(NM_022560.4): c.10 + 1G>T, inherited from her mother) in intron 1 of the GH1 gene and a deletion that encompassed the same gene (chr17: 61973811–61996255, inherited from her father). After hormone replacement therapy with L-thyroxine and recombinant human GH (rhGH), the patient’s thyroid function returned to normal, and her serum IGF-1 level significantly improved, which resulted in an accelerated increase in height. CONCLUSION: This study described a case of IGHD caused by novel compound heterozygous mutations in the GH1 gene. This study suggested that closer attention should be directed to genetic testing and diagnosis based on clinical characteristics to avoid misdiagnosis.
format Online
Article
Text
id pubmed-8411534
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84115342021-09-09 Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report Yang, Xi Yuan, Mingming Li, Zhuoguang Ying, Yanqin Hou, Ling Luo, Xiaoping BMC Med Genomics Case Report BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the clinical data and genetic test results from a patient with IGHD admitted in March 2019 to the Department of Pediatrics Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. We described the results from a 1-year-9-months old female, whose chief complaint was “growth retardation for more than one year”. Her birth length was 49.0 cm, and her birth weight was 3.05 kg. Suboptimal intake (breastfeeding) jaundice lasted for approximately two months following birth. When evaluated at the age of 1-year-9-months old, the patient’s height was 61.0 cm (− 7.24 SD), and her weight was 6.4 kg (− 1.50 SD). The patient’s physical characteristics included yellowish hair, large and unclosed anterior fontanelles, raised forehead, and a low and flat nose. The major abnormalities observed from the auxiliary examinations included low GH (< 0.05 μg/l), low IGF-1 (16.99 μg/l), and elevated TSH (6.97 mIU/l). Genetic testing revealed two heterozygous variants: a splicing mutation (NG_011676.1(NM_022560.4): c.10 + 1G>T, inherited from her mother) in intron 1 of the GH1 gene and a deletion that encompassed the same gene (chr17: 61973811–61996255, inherited from her father). After hormone replacement therapy with L-thyroxine and recombinant human GH (rhGH), the patient’s thyroid function returned to normal, and her serum IGF-1 level significantly improved, which resulted in an accelerated increase in height. CONCLUSION: This study described a case of IGHD caused by novel compound heterozygous mutations in the GH1 gene. This study suggested that closer attention should be directed to genetic testing and diagnosis based on clinical characteristics to avoid misdiagnosis. BioMed Central 2021-09-02 /pmc/articles/PMC8411534/ /pubmed/34470639 http://dx.doi.org/10.1186/s12920-021-01057-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Yang, Xi
Yuan, Mingming
Li, Zhuoguang
Ying, Yanqin
Hou, Ling
Luo, Xiaoping
Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title_full Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title_fullStr Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title_full_unstemmed Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title_short Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
title_sort isolated growth hormone deficiency type ia due to a novel gh1 variant: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411534/
https://www.ncbi.nlm.nih.gov/pubmed/34470639
http://dx.doi.org/10.1186/s12920-021-01057-z
work_keys_str_mv AT yangxi isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport
AT yuanmingming isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport
AT lizhuoguang isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport
AT yingyanqin isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport
AT houling isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport
AT luoxiaoping isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport